T
RMD icon

TCWP’s ResMed RMD Stock Holding History

TCWP’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-53
Closed -$12K – 1419
2022
Q1 		$12K Buy
+53
New +$12.8K ﹤0.01% 844

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

TCWP's RMD Position: Q2 2022 in Review

TCWP sold out of ResMed (RMD) in Q2 2022, closing a stake of 53 shares — an estimated $12K sold.

TCWP first reported a position in RMD in Q1 2022 and held it in 1 quarter. The position peaked at $12K in Q1 2022. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • TCWP reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 53 ResMed shares in Q2 2022, an estimated $12K.
  • TCWP first reported a position in ResMed in Q1 2022 and held it in 1 quarter.
  • TCWP's ResMed position peaked at $12K in Q1 2022.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.